NCCN 20th Annual Conference: Advancing the Standard of Cancer Care™

March 12 – 14, 2015
(Pre-conference programs to take place on Wednesday 3/11/2015)

 

The Diplomat
Hollywood, Florida

 

 

Overview

The NCCN 20th Annual Conference: Advancing the Standard of Cancer Care™ attracts more than 1,500 registrants from across the United States and the globe including oncologists (in both community and academic settings), oncology fellows, nurses, pharmacists, and other health care professionals involved in the care of patients with cancer. Respected opinion leaders present the latest cancer therapies and provide updates on selected NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), the data upon which the NCCN Guidelines® are based, and quality initiatives in oncology. Topics change annually but focus on the major cancers and supportive care areas.

 


 

Wednesday, March 11, 2015*

The following pre-conference programs requiring separate registration are scheduled for
Wednesday, March 11.

2015 NCCN Nursing Program:
Advancing Oncology Nursing™
Wednesday, March 11, 2015 • 8:00 AM – 3:00 PM

This educational event has reached maximum capacity. All registrants from this point on will be placed on a wait-list and will be contacted if a seat becomes available. We encourage you to register and attend the main conference.

Register Now!
NCCN Academy for Excellence & Leadership in Oncology™
School of Pharmaceutical & Biotech Business
Wednesday, March 11, 2015 • 8:20 AM – 2:15 PM

(CME/CE credits are not available for this program.)

Thursday, March 12, 2015*

7:00 – 8:15 AM
Breakfast, Exhibits, and General Poster Session I (Exhibition Hall)

8:15 – 8:25 AM
Welcome and Opening Remarks
Robert W. Carlson, MD
Chief Executive Officer
National Comprehensive Cancer Network

8:25 – 9:10 AM
Keynote Address: 20 Years of Improving the Quality, Effectiveness,
and Efficiency of Cancer Care
(CME/CE credits are not available for this session)
Robert W. Carlson, MD
Chief Executive Officer
National Comprehensive Cancer Network

9:10 – 9:20 AM
Break, Exhibits, and General Poster Session I (Exhibition Hall)

 

New for 2015! Customize Your Learning with Track Sessions

 

9:20 – 10:20 AM Track › choose one
Breakout Room A:
Advances in Management of Early Stage Breast Cancer

Amy Cyr, MD
Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine

Breakout Room B:
Diagnosis and Treatment of NSCLC Using Minimally Invasive Techniques

Thomas A. D'Amico, MD
Duke Cancer Institute

Breakout Room C:
Treatment Milestones in CML: Stay the Course or Change Therapy?

Jerald P. Radich, MD
Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance

10:20 – 10:45 AM
Break, Exhibits, and General Poster Session I (Exhibition Hall)

10:45 – 11:45 AM Track › choose one
Breakout Room A:
Optimizing Treatment of HER2-Positive Breast Cancer

William J. Gradishar, MD
Robert H. Lurie Comprehensive Cancer Center of Northwestern University

Breakout Room B:
Role of Radiation Therapy in Management of SCLC
John C. Grecula, MD
The Ohio State University Comprehensive
Cancer Center - James Cancer Hospital
and Solove Research Institute

Breakout Room C:
Updates to the Management of CLL
William G. Wierda, MD, PhD
The University of Texas MD Anderson Cancer Center

11:45 AM – 1:00 PM
Lunch Break, Exhibits, and General Poster Session I (Exhibition Hall)

 

 

New for 2015! An NCCN Commemorative Event

 

1:00 – 2:20 PM
20 Years of Improving Cancer Care Together – An NCCN Roundtable Discussion
Moderated by: Clifford Goodman, PhD, The Lewin Group

In recognition of NCCN’s 20th Anniversary, this special live Roundtable will be comprised of NCCN leadership – past and present– as well as other stakeholders who have had a significant impact on the development, progression, and success of NCCN over the years; noteworthy historical NCCN accomplishments and events will be discussed, as well as the impact NCCN has had and continues to have on the quality, effectiveness, and efficiency of cancer care so that patients can live better lives. This special 20th Anniversary Roundtable will be filmed and endured on NCCN.org.

This roundtable is sponsored by AbbVie; Boehringer Ingelheim Pharmaceuticals, Inc.; Hologic; ImmunoGen, Inc.; Incyte Corporation; Merck Sharp & Dohme Corp.; and Sigma-Tau Pharmaceuticals, Inc.
As of February 6, 2015

Panelists: Al B. Benson III, MD, Robert H. Lurie Comprehensive Cancer Center of Northwestern University; Robert W. Carlson, MD, National Comprehensive Cancer Network; Timothy J. Eberlein, MD, Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; David McFadden, MS, RPh, Gilead Sciences, Inc.; Lee N. Newcomer, MD, MHA, UnitedHealthCare; Samuel M. Silver, MD, PhD, University of Michigan Comprehensive Cancer Center, Mary Lou Smith, JD, MBA, Research Advocacy Network; and Robert C. Young, MD, RCY Medicine

(CME/CE credits are not available for this session.)

Sponsorship opportunities are available for this roundtable. Please send an e-mail to exhibits@nccn.org.

2:20 – 2:30 PM
Break and Exhibits (Exhibition Hall)

 

New for 2015! Customize Your Learning with Track Sessions

 

2:30 – 3:30 PM Track › choose one
Breakout Room A:
Treatment Options for Advanced Melanoma

John A. Thompson, MD
Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance

Breakout Room B:
Optimizing Systemic Therapy Selection in Metastatic Colorectal Cancer

Axel Grothey, MD
Mayo Clinic Cancer Center

Breakout Room C:
New Treatment Options in Castration-Recurrent Prostate Cancer

Andrew J. Armstrong, MD, ScM
Duke Cancer Institute

3:30 – 3:45 PM
Break and Exhibits (Exhibition Hall)

3:45 – 4:45 PM Track › choose one
Breakout Room A:
Management of Dermatologic Toxicities Associated with Targeted Therapies

Mario E. Lacouture, MD
Memorial Sloan Kettering Cancer Center

Breakout Room B:
Multidisciplinary Management of Pancreatic Cancer

Margaret A. Tempero, MD
UCSF Helen Diller Family Comprehensive Cancer Center

Breakout Room C:
Kidney Cancer: Current and Novel Treatment Options

Eric Jonasch, MD
The University of Texas
MD Anderson Cancer Center

4:45 – 5:30 PM
Free Time

 

Returning in 2015! An NCCN Commemorative Event

5:30 – 7:30 PM
Welcome Reception
Join NCCN for a reception in celebration of our 20th anniversary.

Friday, March 13, 2015*

7:00 – 8:15 AM
Breakfast, Exhibits, and General Poster Session II (Exhibition Hall)

8:15 – 9:45 AM
Roundtable:
Value-Based Decision-Making at the Bedside

Moderated by: Clifford Goodman, PhD, The Lewin Group

Panelists: Peter B. Bach, MD, MAPP, Memorial Sloan Kettering Cancer Center; Stephen B. Edge, MD, Baptist Cancer Center; Linda House, RN, BSN, MSM, Cancer Support Community; Jennifer Malin, MD, Wellpoint/Anthem; James L. Mohler, MD, Roswell Park Cancer Institute

9:45 – 10:00 AM
Break, Exhibits, and General Poster Session II (Exhibition Hall)

 

 

New for 2015! Customize Your Learning with Track Sessions

 

10:00 – 11:00 AM Track › choose one
Breakout Room A:
Management of Localized Melanoma

Daniel G. Coit, MD
Memorial Sloan Kettering Cancer Center

Breakout Room B:
Endoscopic Therapies for Early Stage Esophageal Cancers

Hans Gerdes, MD
Memorial Sloan Kettering Cancer Center

Breakout Room C:
Guideline Update in the Management of Bladder Cancer

Peter E. Clark, MD
Vanderbilt-Ingram Cancer Center

11:00 – 11:15 AM
Break, Exhibits, and General Poster Session II (Exhibition Hall)

11:15 – 12:15 PM
Making NCCN Guidelines Relevant Around the Globe:
The Challenge of Resource Stratification

Benjamin O. Anderson, MD
Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance

Wui-Jin Koh, MD
Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance

12:15 – 1:30 PM
Lunch Break, Exhibits, and General Poster Session II (Exhibition Hall)

12:25 – 1:25 PM
Lunch Symposium
Advances in Ovarian and Cervical Cancers: Case-Based Discussions

(Grand Ballroom West)
Seating is limited and on a first-come, first-seated basis.
Jointly provided by NCCN and Clinical Care Options, LLC

1:30 – 2:30 PM
Principles of Immunotherapy (Part I)
Anthony J. Olszanski, MD, RPh
Fox Chase Cancer Center

2:45 – 3:45 PM Track › choose one
Breakout Room A:
Evolving Treatment Strategies for Triple Negative Breast Cancer

Melinda Telli, MD
Stanford Cancer Institute

Breakout Room B:
Targeted/Emerging Therapies for Metastatic NSCLC

Leora Horn, MD, MSc
Vanderbilt-Ingram Cancer Center

Breakout Room C:
Multiple Myeloma: Current Treatment Approaches and Future Directions

Kenneth C. Anderson, MD
Dana-Farber/Brigham and Women's Cancer Center

4:00 – 5:00 PM Track › choose one
Breakout Room A:
Fertility Preservation and Cancer: Current and Future Strategies

Rebecca H. Johnson, MD
Mary Bridge Children’s Hospital

Breakout Room B:
New NCCN Guidelines: Smoking Cessation for Patients with Cancer

Peter G. Shields, MD
The Ohio State University Comprehensive
Cancer Center – James Cancer Hospital
and Solove Research Institute

Breakout Room C:
Management of Anthracycline-Induced Cardiac Toxicity: Emphasis on Early Recognition and Management in the Cancer Survivor

Crystal S. Denlinger, MD
Fox Chase Cancer Center

Saturday, March 14, 2015*

7:00 – 8:15 AM
Breakfast

8:15 – 9:45 AM
Roundtable: What are the Characteristics of an Optimal Clinical Practice Guideline?
Moderator: F. Marc Stewart, MD, Fred Hutchinson Cancer Research Center/
Seattle Cancer Care Alliance

Panelists: David S. Ettinger, MD, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Michael Kuettel, MD, MBA, PhD, Roswell Park Cancer Institute; Joan S. McClure, MS, National Comprehensive Cancer Network; Mary Lou Smith, JD, MBA, Research Advocacy Network; Andrew D. Zelenetz, MD, PhD, Memorial Sloan Kettering Cancer Center

9:45 – 9:55 AM
Break

9:55 – 10:55 AM
Adjuvant Therapy for NSCLC
Gregory A. Otterson, MD
The Ohio State University Comprehensive
Cancer Center – James Cancer Hospital
and Solove Research Institute

11:00 AM – 12:00 PM
New Therapies for Hormone-Sensitive Advanced Breast Cancer
Ingrid A. Mayer, MD, MSCI
Vanderbilt-Ingram Cancer Center

12:00 – 12:45 PM
Lunch Break

12:45 – 1:45 PM
Emerging Treatment Options for B-cell Lymphomas
Andrew D. Zelenetz, MD, PhD
Memorial Sloan Kettering Cancer Center

1:50 – 2:50 PM
Immunotherapy for Melanoma, Kidney, and Lung Cancers (Part II)
Eric Jonasch, MD
The University of Texas
MD Anderson Cancer Center

Anthony J. Olszanski, MD, RPh
Fox Chase Cancer Center

Gregory A. Otterson, MD
The Ohio State University Comprehensive
Cancer Center – James Cancer Hospital
and Solove Research Institute

*Subject to change.

 

 


 

Exhibitor Information

 

Exhibition Hall Floor Plan

Exhibitor Show Services Kit

Exhibit Application

Advertising Rate Card

Reimbursement Resource Room Application and Contract

 

Organizations who are interested in exhibits or sponsorships are encouraged to send an e-mail to exhibits@nccn.org

 


 

Future NCCN Annual Conference Dates:

  • Thursday, March 31, 2016 – Saturday, April 2, 2016
    Pre-conference programs take place on Wednesday, March 30, 2016

Course details

  • Case Manager: 16.00
  • Health Care Other: 16.00
  • Nurse: 16.00
  • Pharmacist: 16.00
  • Physician: 16.00
  • Tumor Registrar: 16.00
  • Event starts: Thu, Mar 12 2015 - 8:00 am
  • Event ends: Sat, Mar 14 2015 - 3:00 pm
  • Course opens: Thu, Mar 12 2015
  • Course expires: Sat, Mar 14 2015

Target audience

This conference is designed to meet the educational needs of physicians, nurses, pharmacists, and other clinical professionals who manage patients with cancer.

Learning objectives

Following this program, participants should be able to:

  • Integrate into professional practice the most recent clinical advances and key updates of the NCCN Guidelines related to lung cancer, breast cancer, gastrointestinal cancer, genitourinary cancer, hematologic malignancies, skin cancer, and supportive care issues.
  • Summarize the role of the immune system in cancer, identify currently available and emerging immunotherapies, and recognize and manage the adverse effects of these agents.
  • Describe the characteristics of an optimal clinical practice guideline and discuss available options for resource stratification as it relates to making NCCN Guidelines relevant around the globe.
  • Assess whether physicians incorporate quality and value into treatment decisions for patients with cancer.

A detailed list of learning objectives by session will be added in February 2015.

Location

The Diplomat
3555 South Ocean Drive
Hollywood, FL 33019
United States
Accreditation information: 

This conference (with the exception of the Keynote Address and the NCCN 20th Anniversary Roundtable) is approved for AMA PRA Category 1 Credit(s)™ for physicians and is also accredited for nurses and pharmacists. NCCN will also seek approval for case manager and tumor registrar clock hours. View complete accreditation details

Supporters: 

This conference is supported by educational grants from:

  • Actelion
  • AstraZeneca
  • Bristol-Myers Squibb
  • BTG International
  • Celgene Corporation
  • Genentech BioOncology
  • Gilead Sciences, Medical Affairs
  • Lilly
  • Merck
  • Novartis Oncology
  • Pfizer
  • Prometheus Laboratories Inc.
  • Takeda Oncology

This activity was made possible by Pharmacyclics, Inc. and Janssen Biotech, Inc.

This activity is supported by an independent educational grant from sanofi US.

 

This list of conference supporters was last updated on February 19, 2015.

Support is solicited from a broad array of managed care and pharma/biotech companies and organizations. This list will be updated as additional supporters are confirmed. The National Comprehensive Cancer Network® (NCCN®) appreciates that supporting companies recognize NCCN®’s need for autonomy in the development of the content of NCCN® resources. All NCCN Content is produced completely independently.

This activity opens on March 12th, 2015.